These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 19754870)

  • 21. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
    von Stuelpnagel C; Holthausen H; Kluger G
    Eur J Paediatr Neurol; 2007 Nov; 11(6):341-5. PubMed ID: 17442601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures.
    Baulac M; Brodie MJ; Elger CE; Krakow K; Stockis A; Meyvisch P; Falter U
    Epilepsia; 2007 Mar; 48(3):589-92. PubMed ID: 17326794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy.
    Coppola G; Mangano S; Tortorella G; Pelliccia A; Fels A; Romano A; Nardello R; Habetswallner F; Licciardi F; Operto FF; Pascotto A
    Epilepsy Res; 2004 Mar; 59(1):35-42. PubMed ID: 15135165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of levetiracetam in hospitalized patients.
    Falip M; Carreño M; Amaro S; Donaire A; Delgado R; Toledo M; Maestro I
    Epilepsia; 2006 Dec; 47(12):2186-8. PubMed ID: 17201722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures.
    Zhou B; Zhang Q; Tian L; Xiao J; Stefan H; Zhou D
    Epilepsy Behav; 2008 Feb; 12(2):305-10. PubMed ID: 18024209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
    Perry S; Holt P; Benatar M
    J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome.
    García C; Rubio G
    Epilepsy Res; 2009 Aug; 85(2-3):318-20. PubMed ID: 19423296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot study of compassionate use of Levetiracetam in patients with generalised epilepsy.
    Weber S; Beran RG
    J Clin Neurosci; 2004 Sep; 11(7):728-31. PubMed ID: 15337134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disfluent speech in patients with partial epilepsy: beneficial effect of levetiracetam.
    Sechi G; Cocco GA; D'Onofrio M; Deriu MG; Rosati G
    Epilepsy Behav; 2006 Nov; 9(3):521-3. PubMed ID: 16971185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levetiracetam extended release conversion to monotherapy for the treatment of patients with partial-onset seizures: a double-blind, randomised, multicentre, historical control study.
    Chung S; Ceja H; Gawłowicz J; Avakyan G; McShea C; Schiemann J; Lu S
    Epilepsy Res; 2012 Aug; 101(1-2):92-102. PubMed ID: 22516508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levetiracetam monotherapy for children and adolescents with benign rolandic seizures.
    Verrotti A; Coppola G; Manco R; Ciambra G; Iannetti P; Grosso S; Balestri P; Franzoni E; Chiarelli F
    Seizure; 2007 Apr; 16(3):271-5. PubMed ID: 17204435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
    Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
    Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of levetiracetam in children with refractory epilepsy as an add-on trial.
    Tonekaboni SH; Ghazavi M; Karimzadeh P; Mahvelati F; Ghofrani M
    Epilepsy Res; 2010 Aug; 90(3):273-7. PubMed ID: 20619606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study.
    Alsaadi TM; Shatzel A; Marquez AV; Jorgensen J; Farias S
    Seizure; 2005 Mar; 14(2):139-42. PubMed ID: 15694569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of levetiracetam in treating epilepsy associated with other medical conditions.
    Di Bonaventura C; Mari F; Fattouch J; Egeo G; Vaudano AE; Manfredi M; Prencipe M; Giallonardo AT
    Acta Neurol Scand; 2006 Feb; 113(2):82-6. PubMed ID: 16411967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Idiopathic childhood occipital epilepsy].
    Ballesteros García S; Otero Martínez B; Lagunilla Herrero L; Fernández Zurita C; Pérez Méndez C; Solís Sánchez G
    An Esp Pediatr; 2001 Apr; 54(4):340-5. PubMed ID: 11273817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levetiracetam as a treatment option in non-convulsive status epilepticus.
    Rupprecht S; Franke K; Fitzek S; Witte OW; Hagemann G
    Epilepsy Res; 2007 Mar; 73(3):238-44. PubMed ID: 17161587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
    Xiao Z; Li JM; Wang XF; Xiao F; Xi ZQ; Lv Y; Sun HB
    Eur Neurol; 2009; 61(4):233-9. PubMed ID: 19176965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid dosage titration of levetiracetam in children.
    Vaisleib II; Neft RA
    Pharmacotherapy; 2008 Mar; 28(3):393-6. PubMed ID: 18294118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.